Home/Filings/4/0001437749-24-001115
4//SEC Filing

Wong Alvin F 4

Accession 0001437749-24-001115

CIK 0001401667other

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 4:41 PM ET

Size

5.1 KB

Accession

0001437749-24-001115

Insider Transaction Report

Form 4
Period: 2023-12-04
Wong Alvin F
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2023-12-04$3.76/sh280$1,05397,934 total
Footnotes (2)
  • [F1]Adoption date of referenced 10b5-1(c) sell to cover program is: 12-15-2020.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.75 to $3.8401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Issuer

PUMA BIOTECHNOLOGY, INC.

CIK 0001401667

Entity typeother

Related Parties

1
  • filerCIK 0001868855

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:41 PM ET
Size
5.1 KB